{"Q": 1, "answer": "no", "rationale": "The segment describes a vaccine deal but contains no intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17932", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment describes details of a deal.", "method": "llm_batch", "batch_id": "batch_2_5796", "batch_size": 200, "batch_pos": 200, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The verb 'secures' is not a moderate verb from the Q3 list. Scale ('665,000 doses', '40 million vaccines') is present but not paired with a moderate verb describing impact.", "method": "llm_batch", "batch_id": "batch_3_14768", "batch_size": 200, "batch_pos": 141, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_9812", "batch_size": 200, "batch_pos": 138, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports details of vaccine deal without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_21124", "batch_size": 200, "batch_pos": 135, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "'up to 665,000' and 'further 40 million' are not minimisers.", "method": "llm_batch", "batch_id": "batch_6_19520", "batch_size": 200, "batch_pos": 110, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_13916", "batch_size": 200, "batch_pos": 96, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes preparedness measure ('secures up to 665,000 doses', 'option for a further 40 million vaccines') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_14100", "batch_size": 200, "batch_pos": 155, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
